The growing interest in potent weight management has resulted in considerable research into novel treatments. Lately , Retatrutide, a twin-action glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor activator , has exhibited positive results in medical trials, suggesting potential for considerable weight loss . Consequently , numer